[go: up one dir, main page]

MX9704079A - Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores. - Google Patents

Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.

Info

Publication number
MX9704079A
MX9704079A MX9704079A MX9704079A MX9704079A MX 9704079 A MX9704079 A MX 9704079A MX 9704079 A MX9704079 A MX 9704079A MX 9704079 A MX9704079 A MX 9704079A MX 9704079 A MX9704079 A MX 9704079A
Authority
MX
Mexico
Prior art keywords
composition
goam
hydrocoloid
uan
release
Prior art date
Application number
MX9704079A
Other languages
English (en)
Inventor
Eric H Kuhrts
David R Friend
Karen Yu
Jagdish Parasrampuria
Original Assignee
Cibus Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cibus Pharmaceutical Inc filed Critical Cibus Pharmaceutical Inc
Publication of MX9704079A publication Critical patent/MX9704079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composicion farmacéutica de suministracion oral para reducir el efecto de irritacion gástrica de un AINE en el tracto GI superior de un mamífero. La composicion incluye (a) una cantidad protectora de la mucosa de una goma hidrocoloide farmacéuticamente aceptable obtenible a partir de plantas superiores, (b) una cantidad mejoradora de dispersion de otro excipiente y (c) una cantidad terapéuticamente efectiva de un ATNE. Se describe también un procedimiento para preparar la composicion y un método para reducir el efecto de irritacion gástrica del AINE al administrar la composicion. Asimismo, se describe una composicion particularmente util para preparar una suspension acuosa.
MX9704079A 1994-12-01 1995-11-30 Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores. MX9704079A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34760194A 1994-12-01 1994-12-01
PCT/US1995/015599 WO1996016639A1 (en) 1994-12-01 1995-11-30 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants

Publications (1)

Publication Number Publication Date
MX9704079A true MX9704079A (es) 1997-12-31

Family

ID=23364417

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704079A MX9704079A (es) 1994-12-01 1995-11-30 Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.

Country Status (8)

Country Link
EP (1) EP0804169A4 (es)
JP (1) JPH10509982A (es)
AU (1) AU690417B2 (es)
CA (1) CA2205442C (es)
FI (1) FI972305A7 (es)
MX (1) MX9704079A (es)
NO (1) NO972485L (es)
WO (1) WO1996016639A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
DE69739165D1 (de) * 1996-07-08 2009-01-29 Penwest Pharmaceuticals Co Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
CN1165293C (zh) * 1998-08-21 2004-09-08 诺瓦提斯公司 5ht4激动剂或拮抗剂的新型口服制剂
RU2260424C9 (ru) * 1998-08-21 2006-05-20 Новартис Аг Новая композиция для перорального введения
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers
EP4069209A4 (en) * 2019-12-05 2024-04-10 Flagship Pioneering Innovations V, Inc. ACYLATED ACTIVE AGENTS AND METHODS OF USE THEREOF FOR THE TREATMENT OF METABOLIC DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE
JP7782842B2 (ja) * 2022-06-02 2025-12-09 株式会社パウレック 速崩壊性圧縮成形物の製造方法および速崩壊性圧縮成形物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327938A (en) * 1969-12-17 1973-08-22 Sucrest Corp Composition for use in forming tablets
DE2130545A1 (de) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
WO1986006627A1 (en) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Sustained release theophylline compositions and processes
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
AU5745394A (en) * 1992-12-30 1994-08-15 Fmc Corporation Readily available konjac glucomannan sustained release excipient

Also Published As

Publication number Publication date
FI972305A0 (fi) 1997-05-30
EP0804169A1 (en) 1997-11-05
EP0804169A4 (en) 1998-08-19
AU4595196A (en) 1996-06-19
FI972305L (fi) 1997-05-30
WO1996016639A1 (en) 1996-06-06
NO972485D0 (no) 1997-05-30
NO972485L (no) 1997-07-31
FI972305A7 (fi) 1997-05-30
CA2205442C (en) 2003-01-21
AU690417B2 (en) 1998-04-23
JPH10509982A (ja) 1998-09-29
CA2205442A1 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
WO2003047519A3 (en) 'compressed annular tablet with molded triturate tablet for oral and intraoral'
AU725283B2 (en) Bioadhesive pharmaceutical composition for the controlled release of active principles
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
BR0307473A (pt) Forma de dosagem farmacêutica para distribuição por via mucosa
ATE280572T1 (de) Verabreichung von arzneistoffen im unteren verdauungstrakt
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
MY126555A (en) Oral pharmaceutical extended release dosage form
MX9804008A (es) Formulaciones farmaceuticas.
AR005231A1 (es) Una forma farmaceutica de dosificación adaptada para la administración oral, que comprende darifenacina, o una de sus sales farmacéuticamente aceptables, y un procedimiento para producirla.
DE69819351D1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
DE69615704D1 (de) Bioadhesive feste arzneimittelform
MX9704079A (es) Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
BR0212155A (pt) Composição farmacêutica
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
AR001765A1 (es) Una formulación de liberación prolongada un procedimiento para su preparación una forma cristalina de cisaprida-(l)-tartrato y un medicamento util para el tratamiento de trastornos gastrointestinales
RU2004129284A (ru) Амброксол для лечения болей в полости рта и глотки
BE1002182A5 (fr) Compositions pharmaceutiques.
BRPI0415322A (pt) composição farmacêutica antiretroviral, processo para a preparação de uma composição farmacêutica antiretroviral, método para reduzir a carga de consumo de pìlulas para um paciente, método para aumentar a meia-vida in vivo de lamivudina e de zidovudina enquanto não afetando a meia-vida de nevirapina
MX9704043A (es) Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
ATE238775T1 (de) Entzündungshemmende pharmazeutische formulierungen
DK1448184T3 (da) Anvendelse af propionyl-L-carnitin eller et af dets farmakologisk acceptable salte til fremstilling af en medicin til behandling af Peyronies sygdom